Uncoupling protein 2 regulates metabolic reprogramming and fate of antigen-stimulated CD8+ T cells

Cancer Immunology, Immunotherapy

Volumn 65, Issue 7, 2016, Pages 869-874

  Chaudhuri, Leena ^a   Srivastava, Rupesh K ^a,b   Kos, Ferdynand ^a,c   Shrikant, Protul A ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b DR H S GOUR UNIVERSITY   (India)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

CD8+ T cell fate; CITIM 2015; Metabolic reprogramming; Uncoupling protein 2

Indexed keywords

CD8 ANTIGEN; CELL PROTEIN; FATTY ACID; GAMMA INTERFERON; GENIPIN; KLRG1 PROTEIN; L SELECTIN; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; EPITOPE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANTIGEN SPECIFICITY; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL CLONE; CELL EXPANSION; CELL FATE; CELL SURVIVAL; EFFECTOR CELL; FATTY ACID SYNTHESIS; GLYCOLYSIS; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; MEMORY CELL; METABOLIC REGULATION; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; CELL DIFFERENTIATION; HUMAN; IMMUNOLOGY; PROCEDURES;

CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; UNCOUPLING PROTEIN 2;

EID: 84976328182     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-016-1851-4     Document Type: Review

References (30)

1. Buck MD, O’Sullivan D, Pearce EL (2015) T cell metabolism drives immunity. J Exp Med 212(9):1345–1360. doi:10.1084/jem.20151159
2. Lunt SY, Vander Heiden MG (2011) Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27:441–464. doi:10.1146/annurev-cellbio-092910-154237
3. MacIver NJ, Michalek RD, Rathmell JC (2013) Metabolic regulation of T lymphocytes. Annu Rev Immunol 31:259–283. doi:10.1146/annurev-immunol-032712-095956
4. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029–1033. doi:10.1126/science.1160809
5. Sena LA, Li S, Jairaman A, Prakriya M, Ezponda T, Hildeman DA, Wang CR, Schumacker PT, Licht JD, Perlman H, Bryce PJ, Chandel NS (2013) Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38(2):225–236. doi:10.1016/j.immuni.2012.10.020
6. Devadas S, Zaritskaya L, Rhee SG, Oberley L, Williams MS (2002) Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J Exp Med 195(1):59–70
7. Murphy MP, Siegel RM (2013) Mitochondrial ROS fire up T cell activation. Immunity 38(2):201–202. doi:10.1016/j.immuni.2013.02.005
8. Wang R, Green DR (2012) Metabolic checkpoints in activated T cells. Nat Immunol 13(10):907–915. doi:10.1038/ni.2386
9. van der Windt GJ, Everts B, Chang CH, Curtis JD, Freitas TC, Amiel E, Pearce EJ, Pearce EL (2012) Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36(1):68–78. doi:10.1016/j.immuni.2011.12.007
10. Criscuolo F, Mozo J, Hurtaud C, Nubel T, Bouillaud F (2006) UCP2, UCP3, avUCP, what do they do when proton transport is not stimulated? Possible relevance to pyruvate and glutamine metabolism. Biochim Biophys Acta 1757(9–10):1284–1291. doi:10.1016/j.bbabio.2006.06.002
11. Pecqueur C, Alves-Guerra C, Ricquier D, Bouillaud F (2009) UCP2, a metabolic sensor coupling glucose oxidation to mitochondrial metabolism? IUBMB Life 61(7):762–767. doi:10.1002/iub.188
12. Pecqueur C, Bui T, Gelly C, Hauchard J, Barbot C, Bouillaud F, Ricquier D, Miroux B, Thompson CB (2008) Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization. FASEB J 22(1):9–18. doi:10.1096/fj.07-8945com
13. Arsenijevic D, Onuma H, Pecqueur C, Raimbault S, Manning BS, Miroux B, Couplan E, Alves-Guerra MC, Goubern M, Surwit R, Bouillaud F, Richard D, Collins S, Ricquier D (2000) Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26(4):435–439. doi:10.1038/82565
14. Bai Y, Onuma H, Bai X, Medvedev AV, Misukonis M, Weinberg JB, Cao W, Robidoux J, Floering LM, Daniel KW, Collins S (2005) Persistent nuclear factor-kappa B activation in Ucp2-/- mice leads to enhanced nitric oxide and inflammatory cytokine production. J Biol Chem 280(19):19062–19069. doi:10.1074/jbc.M500566200
15. Kizaki T, Suzuki K, Hitomi Y, Taniguchi N, Saitoh D, Watanabe K, Onoe K, Day NK, Good RA, Ohno H (2002) Uncoupling protein 2 plays an important role in nitric oxide production of lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci USA 99(14):9392–9397. doi:10.1073/pnas.142206299
16. Rupprecht A, Brauer AU, Smorodchenko A, Goyn J, Hilse KE, Shabalina IG, Infante-Duarte C, Pohl EE (2012) Quantification of uncoupling protein 2 reveals its main expression in immune cells and selective up-regulation during T-cell proliferation. PLoS One 7(8):e41406. doi:10.1371/journal.pone.0041406
17. Kaminski M, Kiessling M, Suss D, Krammer PH, Gulow K (2007) Novel role for mitochondria: protein kinase Ctheta-dependent oxidative signaling organelles in activation-induced T-cell death. Mol Cell Biol 27(10):3625–3639. doi:10.1128/mcb.02295-06
18. Bouillaud F (2009) UCP2, not a physiologically relevant uncoupler but a glucose sparing switch impacting ROS production and glucose sensing. Biochim Biophys Acta 1787(5):377–383. doi:10.1016/j.bbabio.2009.01.003
19. Emre Y, Nubel T (2010) Uncoupling protein UCP2: when mitochondrial activity meets immunity. FEBS Lett 584(8):1437–1442. doi:10.1016/j.febslet.2010.03.014
20. Locasale JW, Cantley LC (2011) Metabolic flux and the regulation of mammalian cell growth. Cell Metab 14(4):443–451. doi:10.1016/j.cmet.2011.07.014
21. Joseph JW, Jensen MV, Ilkayeva O, Palmieri F, Alarcon C, Rhodes CJ, Newgard CB (2006) The mitochondrial citrate/isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion. J Biol Chem 281(47):35624–35632. doi:10.1074/jbc.M602606200
22. Zhang J, Khvorostov I, Hong JS, Oktay Y, Vergnes L, Nuebel E, Wahjudi PN, Setoguchi K, Wang G, Do A, Jung HJ, McCaffery JM, Kurland IJ, Reue K, Lee WN, Koehler CM, Teitell MA (2011) UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J 30(24):4860–4873. doi:10.1038/emboj.2011.401
23. Vozza A, Parisi G, De Leonardis F, Lasorsa FM, Castegna A, Amorese D, Marmo R, Calcagnile VM, Palmieri L, Ricquier D, Paradies E, Scarcia P, Palmieri F, Bouillaud F, Fiermonte G (2014) UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation. Proc Natl Acad Sci USA 111(3):960–965. doi:10.1073/pnas.1317400111
24. Weinberg SE, Sena LA, Chandel NS (2015) Mitochondria in the regulation of innate and adaptive immunity. Immunity 42(3):406–417. doi:10.1016/j.immuni.2015.02.002
25. Gattinoni L, Zhong XS, Palmer DC, Ji Y, Hinrichs CS, Yu Z, Wrzesinski C, Boni A, Cassard L, Garvin LM, Paulos CM, Muranski P, Restifo NP (2009) Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med 15(7):808–813. doi:10.1038/nm.1982
26. Wherry EJ, Teichgrӓber V, Becker TC, Masopust D, Kaech SM, Antia R, von Andrian UH, Ahmed R (2003) Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4(3):225–234. doi:10.1038/ni889
27. Sukumar M, Liu J, Ji Y, Subramanian M, Crompton JG, Yu Z, Roychoudhuri R, Palmer DC, Muranski P, Karoly ED, Mohney RP, Klebanoff CA, Lal A, Finkel T, Restifo NP, Gattinoni L (2013) Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J Clin Invest 123(10):4479–4488. doi:10.1172/jci69589
28. Topalian SL, Drake CG, Pardoll DM (2015) Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27(4):450–461. doi:10.1016/j.ccell.2015.03.001
29. Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12(4):252–264. doi:10.1038/nrc3239
30. Patsoukis N, Bardhan K, Chatterjee P, Sari D, Liu B, Bell LN, Karoly ED, Freeman GJ, Petkova V, Seth P, Li L, Boussiotis VA (2015) PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun 6:6692. doi:10.1038/ncomms7692